Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?
Eva A Turley, Mandana Veiseh, Derek C Radisky and Mina J Bissell*
Correspondence *Life Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, MS 977, Berkeley, CA 94720, USA
Email mjbissell@lbl.gov
Epithelial–mesenchymal transition (EMT) is a phenotypic conversion that facilitates organ morphogenesis and tissue remodeling. The authors of this Review discuss the phenomenon of EMT in relation to tumor development, and the function of EMT in promoting invasion and metastasis. The roles of ERK1, ERK2 and PI3-kinase, as microenvironmental responsive regulators of EMT are also highlighted.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Leading the chargeNature Cell Biology News and Views (01 Dec 2007)
Cancer: the matrix is now in controlNature Medicine News and Views (01 Nov 2005)
See all 5 matches for News And ViewsRESEARCH
Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cellsCell Research Original Article
Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial?mesenchymal transitionOncogene Original Article
See all 52 matches for Research
